HOTTIP and ovarian cancer: For this study, we focused on the lncRNA HOTTIP because of its immense potential as a biomarker (Lian et al., 2016; Fan et al., 2018) but without any prior exploration in cisplatin resistance of ovarian cancer even though there is an indication for it role in cisplatin resistance of other human cancers (Yin et al., 2020).